COMBIGENE AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.43 SEK | -1.44% |
|
-7.30% | +27.51% |
| Mar. 13 | CombiGene's Epilepsy Project CG01 Receives Patent in Two New Countries | CI |
| Feb. 21 | Orphazyme A/S acquired an additional unknown minority stake in CombiGene AB (OM:COMBI). | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| COMBIGENE AB | Bio Therapeutic Drugs | -1.44% | -7.30% | +27.51% | -52.69% | -87.39% | 6.35M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- COMBI Stock
- Charts CombiGene AB
- Comparison Chart
